2 Aug

Biopharma companies still waiting for clarity on China’s new patent term extension regime

With patent linkage coming into force in China last month, biopharma innovators should now turn their attention to the uncertainties surrounding the country’s fledgling term extensions system

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth